The Cartagena Protocol on Biosafety that was adopted by governments on 29 January 2000 is the main international legally binding treaty that regulates ?the safe transfer, handling and use of living modified organisms resulting from modern biotechnology? that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health?.

It is significant as the first global treaty to attempt to contribute to the protection of biodiversity and human health in this field, and as the first treaty to operationalise the precautionary approach in decision-making relating to imports under the Protocol. As of 22 February 2005, there are 113 Parties to the Protocol.

Although the Protocol focuses on transboundary movements of GMOs, its provisions do influence national and regional biosafety policies and laws, bearing in mind that the Protocol sets minimum requirements and Parties have the right to formulate more comprehensive national laws with higher standards. This is reaffirmed in Article 2(4).

Meanwhile, work and standard setting are also taking place in other international fora, such as the Codex Alimentarius, the International Plant Protection Convention and the International Office of Epizootics, the UN Food and Agriculture Organisation and the World Health Organisation.

The linkages among trade, environment and health means that developments at the World Trade Organisation also impact on biosafety and vice versa.

A field of growing importance is the development of biological weapons as part of biodefence programmes where the adequacy of global rules and standards needs examinination.

European Communities – Measures Affecting the Approval and Marketing of Biotech Products

Three countries led by the US have submitted a complaint to the WTO over the EU’s authorisation system for GMOs. This paper discusses the issues with respect to EU’s measures affecting the approval and marketing of GMOs and products derived from GMOs. […]

National Implementation of the Cartagena Protocol on Biosafety: Some Key Issues

Lim Li Lin discusses some of the issues related to the implementation of the Cartagena Protocol on Biosafety as they relate to its implementation at the national level. […]

Governments form GM-free zones, ban GMOs

As concerns grow over the environmental and human and animal health effects of genetic engineering, governments in some countries are taking action to protect their people and territory. […]

NGOs urge WHO to reject genetic engineering of smallpox

An international alliance of NOGs launched a campaign to urge the WHO to reject a proposal that would permit the genetic engineering of smallpox. […]

Brazil, New Zealand block decision on documentation of GMOs

A report on the outcome of the Second Meeting of the Parties to the Cartagena Protocol on Biosafety in Montreal, 30 May – 3 June, 2005. […]

Submission to Ministry of Foreign Affairs and Trade concerning the second meeting of the Parties to the Cartagena Protocol on Biosafety

Submission of the New Zealand Institute of Gene Ecology to Ministry of Foreign Affairs and Trade concerning the second meeting of the Parties to the Cartagena Protocol on Biosafety, Montreal 30 May-3 June 2005 […]

The Genetic Engineering of Smallpox

A briefing paper on the campaign by the Sunshine Project and Third World Network to stop the genetic modification of smallpox virus. […]

No agreement at Biosafety Protocol experts’ meeting

A report on the outcome of the first expert group’s meeting on Art. 18.2(a), 16-18 April 2005. […]

Third Party Submission by Norway to the WTO (Chinese)

挪威政府第三当事方提呈欧共体的措施给世贸争端解决小组 事关影响生&#292 […]

Third Party Submission by Norway to the WTO

Norwegian Government’s Third Party Submission to the WTO dispute settlement panel in the case of ‘European Communities Measures Affecting the Approval and Marketing of Biotech Products”. […]